NSGC Online Education Center

Catalog Advanced Search

Search by Category
Search by Format
Search by Type
Sort By
Search by Favorites
Search by Keyword
Search by Category
Search by Format
Search by Type
Search by Speakers
Credits Offered
Search in Packages
Search by Date Range
Products are filtered by different dates, depending on the combination of live and on-demand components that they contain, and on whether any live components are over or not.
Start
End
Search by Favorites
Search by Keyword
Sort By
  • Contains 1 Component(s) Includes a Live Web Event on 08/05/2026 at 12:00 PM (CDT)

    Presented by the NSGC Pediatrics and Clinical Genetics SIG

    Genetic testing for pediatric neurodevelopmental disorders has evolved rapidly, with genome sequencing now recognized as a first-tier diagnostic test in updated professional guidelines. This webinar will review the evidence driving this shift, compare historical and current testing approaches, discuss practical considerations for implementation, including insurance coverage and test selection, and highlight clinical cases in which genome sequencing identified diagnoses that would likely have been missed by previous first-tier technologies. Attendees will gain practical knowledge to support evidence-based genetic counseling, educate referring providers on current testing recommendations, and incorporate genome sequencing into clinical practice to improve diagnostic outcomes for pediatric patients.

    Presented by: 

    NSGC Pediatrics and Clinical Genetics SIG
    Emily Muth, MS, CGC
    Jillian Kirk, MS, CGC

    Learning Objectives:

    1. Describe recent changes in professional guidelines supporting genome sequencing as a first-tier diagnostic test for pediatric patients with neurodevelopmental conditions.
    2. Apply evidence from clinical case examples to identify scenarios in which genome sequencing can provide diagnoses that would likely be missed using older testing strategies.
    3. Discuss practical considerations for implementing genome sequencing in clinical practice, including insurance coverage, test selection, and genetic counseling implications.
    4. Describe how provider education on current genetic testing recommendations can facilitate earlier diagnosis of neurodevelopmental conditions, improving access and promoting equitable care. 

    Emily Muth, MS, CGC

    Emily Muth, MS, CGC

    Emily Muth, MS, CGC is a board-certified pediatric genetic counselor at Children’s Hospital Colorado, where she has worked since 2023. She primarily sees patients in general genetics as well as multiple subspecialties. Emily has enjoyed being part of the Pediatric SIG to support collaboration, resource and knowledge sharing, and the continued growth of the pediatric genetic counseling community.

    Jillian Kirk, MS, CGC

    Jillian Kirk, MS, CGC

    Jillian Kirk, MS, CGC, is a board-certified genetic counselor at New Jersey Pediatric Neuroscience Institute seeing patients with a range of neurological, developmental, and craniofacial indications. She graduated from the University of Colorado Genetic Counseling Graduate Program where she completed the Leadership Education in Neurodevelopmental Disabilities (LEND) fellowship program. Her previous experience includes genetic counseling in preconception and prenatal care as well as adult oncology.

    Laura Hendon, MA, MS, CGC

    Laura Hendon, MA, MS, CGC (Moderator)

  • Contains 1 Component(s) Includes a Live Web Event on 07/29/2026 at 12:00 PM (CDT)

    Presented by the NSGC International SIG

    This webinar explores the evolving genetic counseling landscapes in Hong Kong and the Dominican Republic, highlighting both opportunities and challenges in expanding access to care. The first half provides an overview of genetic counseling in Hong Kong, including training pathways, service delivery, genetic testing infrastructure, and barriers to workforce development and patient access. The second half offers a first-hand perspective on establishing a genetic counseling practice in the Dominican Republic, examining legal and certification challenges, clinical practice across reproductive and pediatric settings, and obstacles to genetic testing. Participants will gain insight into how genetic counseling is delivered in two distinct healthcare systems and the practical realities of advancing the profession in emerging regions. The session concludes with a call for global collaboration, advocacy, and resource sharing to strengthen genetic counseling services worldwide.

    Presented by: 

    NSGC International SIG
    Yoyo (Wing Yiu) Chu, MGenCoun, FHGSA (Genetic Counselling)
    Camila M. Marranzini, MS, GC

    Learning Objectives:

    1. Summarize the education, training pathways, and professional roles of genetic counselors in Hong Kong, including available programs and integration within public and private healthcare systems.
    2. Describe the regulatory framework, minimum practice requirements, and certification barriers affecting genetic counselors in the Dominican Republic, including challenges related to international credentialing systems (ABGC, EBMG).
    3. Analyze structural and systemic barriers to genetic testing access in both Hong Kong and the Dominican Republic, including cost, insurance coverage, infrastructure limitations, and disparities compared to higher-resource settings.
    4. Evaluate how cultural, religious, and socioeconomic factors influence the delivery of genetic counseling and clinical practice adaptations in resource-limited settings.

  • Contains 4 Component(s), Includes Contact Hours

    This webinar will explore genetic counseling practices across Latin America through the experiences of two US-trained genetic counselors currently practicing abroad. Speakers will highlight key differences in healthcare systems, access to genetic testing, and clinical workflows, with a focus on challenges and barriers faced by patients outside the United States.

    This webinar will explore genetic counseling practices across Latin America through the experiences of two US-trained genetic counselors currently practicing abroad. Speakers will highlight key differences in healthcare systems, access to genetic testing, and clinical workflows, with a focus on challenges and barriers faced by patients outside the United States. The session will also address important considerations for US-based genetic counselors working with Spanish-speaking patients who have cross-border care needs. Attendees will gain practical insights to support more effective communication, care coordination, and culturally informed practice.

    Presented by:

    NSGC Spanish Development SIG
    Gabriela Valverde de Morales, MD
    Sonia Margarit, MS, CGC

    Learning Objectives:

    1. Compare genetic counseling practices across the United States and Latin America, including differences in healthcare systems, testing access, and clinical approaches.
    2. Identify key challenges and barriers affecting non-US patients’ access to genetic counseling and testing in Latin America, including system-level, logistical, and resource-related limitations.
    3. Apply practical strategies to improve communication, care coordination, and decision-making in cross-border genetic counseling contexts.
    4. Recognize opportunities for collaboration and resource-sharing to better support continuity of care for patients and families navigating genetic services across countries.

    Genetic Counselor CEUs

    The National Society of Genetic Counselors (NSGC) has authorized the National Society of Genetic Counselors (NSGC) to offer up to .1 CEUs or 1 Category 1 contact hours for the activity, Genetic Counseling in Latin America: Perspectives from US-Trained Providers. The American Board of Genetic Counseling (ABGC) will accept CEUs earned by participating in this program for the purposes of genetic counselor recertification.

    Successful Completion:

    1. View recording
    2. Pass quiz
    3. Complete evaluation

  • Contains 12 Product(s)

    This all-inclusive package offers access to the full set of 24 webinars from NSGC’s 2026 Webinar Series, complete with CEUs. Please note that webinars will be added to this package as they are released.

    This all-inclusive package offers access to the full set of 24 webinars from NSGC’s 2026 Webinar Series, complete with CEUs. Please note that webinars will be added to this package as they are released.

    To purchase the 2026 NSGC Webinar Series Full Package, click the blue "Register Now" button next to the package title. Do not register for the individual components included in the package.

    Genetic Counselor CEUs:
    The National Society of Genetic Counselors (NSGC) has authorized the National Society of Genetic Counselors (NSGC) to offer up to 2.4 CEUs or 24 Category 1 contact hours for the 2026 NSGC Webinar Series Full Package. The American Board of Genetic Counseling (ABGC) will accept CEUs earned by participating in this program for the purposes of genetic counselor recertification.

  • Contains 4 Component(s), Includes Contact Hours

    This webinar will provide an extensive review of hereditary cancer syndromes that confer risk for gastric cancer and other gastric neoplasia.

    This webinar will provide an extensive review of hereditary cancer syndromes that confer risk for gastric cancer and other gastric neoplasia. This review will include discussion of genetic testing strategies, current cancer risk estimates, and management of these syndromes from a patient-centric perspective. This webinar will also include a review of non-genetic risk factors and prevention strategies.

    Presented by:

    NSGC Cancer SIG
    Sonia Kupfer, MD
    Emma Keel, MS, CGC

    Learning Objectives:

    1. Define cancer risks associated with hereditary gastric cancer syndromes.
    2. Review risk factors and general prevention for gastric cancer.
    3. Examine the paradigm shift in the management of Hereditary Diffuse Gastric Cancer patients.
    4. Apply new cancer risk estimates and emerging management guidelines to real world cases.

    Genetic Counselor CEUs: 

    The National Society of Genetic Counselors (NSGC) has authorized the National Society of Genetic Counselors (NSGC) to offer up to .1 CEUs or 1 Category 1 contact hour for the activity, What’s Genetics 'Gut' to do with it? A Review of Hereditary Gastric Cancer Syndromes. The American Board of Genetic Counseling (ABGC) will accept CEUs earned by participating in this program for the purposes of genetic counselor recertification.

    Successful Completion: 

    1. View recording
    2. Pass quiz
    3. Complete evaluation

  • Contains 6 Component(s)

    The Journal of Genetic Counseling Articles CEU Program is designed to help genetic counselors stay abreast of research occurring within the field, and provide additional learning and CEU opportunities in an on-demand, self-paced format.

    Program Overview

    Module Number and Release DateModule ContentContact Hours
    Module 1 - April

    3 JoGC Articles, 1 Quiz, plus module evaluation

    3.0
    Module 2 - July

    3 JoGC Articles, 1 Quiz, plus module evaluation

    3.0
    Module 3 - September

    3 JoGC Articles, 1 Quiz, plus module evaluation

    3.0
    Module 4 - November

    3 JoGC Articles, 1 Quiz, plus module evaluation

    3.0
     Total 12.0

    Please Note: You are not required to complete all modules of the JoGC CEU Program to earn CEUs and you may earn partial credit for the program. You may choose to complete some or all modules. You will only be awarded CEUs for those modules which you pass and complete in full, including the module quiz and evaluation. Please review the CEU credit section below for additional information on available contact hours and certificates.

    Continuing Education Unit (CEU) Credits

    The Journal of Genetic Counseling CEU Program is approved for 12.0 Contact Hours or 1.2 Category 1 CEU. The American Board of Genetic Counseling (ABGC) will accept CEUs earned at this program for the purposes of genetic counselor certification and recertification. Individuals must be certified at the time of participation in the activity in order to count towards recertification. 

    Register by November 30, 2026 to participate. Program materials must be completed by December 11, 2026 to earn CEUs. CEU certificates will be issued via the NSGC CEU Portal no later than December 18, 2026. Early certificates are not available. 

    Access to the Journal of Genetic Counseling (JoGC) is required to participate in the 2026 Journal of Genetic Counseling CEU Program. NSGC members receive complimentary access to the Journal of Genetic Counseling. Please note that non-members are required to purchase access to the Journal of Genetic Counseling separately if they do not already have access to this publication to participate in this program.

  • Contains 4 Component(s), Includes Contact Hours

    In this webinar, viewers will explore common clinical scenarios that result from CFTR screening and testing modalities and offer strategies to promote a nuanced approach to genetic counseling about CFTR variants in the context of conflicting classifications.

    The cystic fibrosis (CF) genetic testing and counseling landscape is rapidly evolving. Transformative CFTR modulator therapies have improved length and quality of life for people with CF, while advanced screening detects CFTR variants that confer a wide and variable phenotypic spectrum, including variants associated with low or reduced penetrance. In this webinar, we will explore common clinical scenarios that result from CFTR screening and testing modalities and offer strategies to promote a nuanced approach to genetic counseling about CFTR variants in the context of conflicting classifications.

    Presented by:

    NSGC Cystic Fibrosis and CFTR Spectrum SIG
    Elinor Langfelder-Schwind, MS, CGC
    Emily Calamaro, MGC, CGC
    Charlotte Close, MS, CGC
    Angel Wooden, MS, CGC

    Learning Objectives:

    1. Apply reproductive genetic counseling principles to support family-building for individuals with cystic fibrosis in the era of highly effective CFTR modulator therapies.
    2. Compare approaches to preconception/prenatal and newborn screening for cystic fibrosis with respect to potential diagnostic outcomes and associated management recommendations
    3. Evaluate clinical and genetic factors associated with cystic fibrosis and CFTR-related conditions and their implications for patient monitoring and counseling
    4. Synthesize CFTR variant interpretation resources to inform nuanced genetic counseling about unexpected CFTR findings

    Genetic Counselors CEUs: 

    The National Society of Genetic Counselors (NSGC) has authorized the National Society of Genetic Counselors (NSGC) to offer up to .1 CEUs or 1 Category 1 contact hour for the activity, The Evolving Complexity of CFTR Testing and Counseling: A Case-Based Approach. The American Board of Genetic Counseling (ABGC) will accept CEUs earned by participating in this program for the purposes of genetic counselor recertification.

    Successful Completion: 

    1. View recording
    2. Pass quiz
    3. Complete evaluation

  • Contains 4 Component(s), Includes Contact Hours

    Inherited cardiomyopathies are common conditions with estimated prevalence of 1 in 250. Inherited Arrhythmia conditions are rare with estimated prevalence of ~ 1 in 1000. Inclusion of these conditions in the ACMG secondary findings (SF) list was intended to identify individuals at increased risk that could benefit from early detection and treatment.

    Inherited cardiomyopathies are common conditions with estimated prevalence of 1 in 250. Inherited Arrhythmia conditions are rare with estimated prevalence of ~ 1 in 1000. Inclusion of these conditions in the ACMG secondary findings (SF) list was intended to identify individuals at increased risk that could benefit from early detection and treatment. However, these conditions have reduced penetrance and SFs are quite frequent. The risk assessment is not one-size fits all. What is the current data on the pathogenicity of variants detected incidentally? What is the best plan of care in the absence of expert consensus? This session is designed to inform the learner of where we started and where we are now in terms of personalized risk assessment and management.

    Presented by:

    NSGC Cardiogenetics SIG
    Erin Miller, MS, CGC
    Sarah Jurgensmeyer Langas, MS, CGC
    Laura Zahavich, MSc, CGC

    Learning Objectives: 

    1. Apply clinical phenotype and family history to guide surveillance strategies for individuals with secondary findings in cardiac disease genes.
    2. Identify key molecular, clinical, and family history indicators to guide genetic counseling for patients with secondary findings in genes associated with cardiomyopathy risks.
    3. Understand and anticipate implications of secondary findings in inherited arrhythmia genes

    Genetic Counselor CEUs: 

    The National Society of Genetic Counselors (NSGC) has authorized the National Society of Genetic Counselors (NSGC) to offer up to .1 CEUs or 1 Category 1 contact hour for the activity, From Sequence to Surveillance: Making Sense of Secondary Findings in Inherited Arrhythmia and Cardiomyopathy Genes. The American Board of Genetic Counseling (ABGC) will accept CEUs earned by participating in this program for the purposes of genetic counselor recertification.

    Successful Completion: 

    1. View recording
    2. Pass quiz
    3. Complete evaluation

  • Contains 4 Component(s), Includes Contact Hours

    This webinar will begin with background information on preimplantation genetic testing for aneuploidies (PGT-A) and mosaicism, including differences in lab reporting, historical viewpoints about mosaicism and transfer policies (and how that has evolved over time), and a quick summary of current literature on outcomes.

    This webinar will begin with background information on preimplantation genetic testing for aneuploidies (PGT-A) and mosaicism, including differences in lab reporting, historical viewpoints about mosaicism and transfer policies (and how that has evolved over time), and a quick summary of current literature on outcomes. The webinar will continue with how non-euploid embryo transfers are managed in a prenatal clinic, what testing (if any) patients are pursuing prenatally and/or postnatally, what the prenatal clinic is finding regarding outcomes and general trends, and cases examples.

    Presented by:

    NSGC Assisted Reproductive Technologies/Infertility SIG
    Emma Moores, MGC, CGC
    Jennifer Kussmann, MS, CGC

    Learning Objectives:

    1. Review the background on PGT-A testing with non-euploid results
    2. Describe the historical viewpoints and current embryo transfer policies
    3. Explain prenatal testing and screening options
    4. Identify case examples to highlight the challenges in pregnancies with atypical embryos

    Genetic Counselor CEUs: 

    The National Society of Genetic Counselors (NSGC) has authorized the National Society of Genetic Counselors (NSGC) to offer up to .1 CEUs or 1 Category 1 contact hour for the activity, The Mosaic Journey: From Transfer to Term. The American Board of Genetic Counseling (ABGC) will accept CEUs earned by participating in this program for the purposes of genetic counselor recertification.

    Successful Completion: 

    1. View recording
    2. Pass quiz
    3. Complete evaluation

  • Contains 34 Product(s)

    This is a focused package covering plenary, educational breakout, and on-demand sessions from the NSGC 44th Annual Conference.

    This is a focused package covering plenary, educational breakout, and on-demand sessions from the NSGC 44th Annual Conference.

    To purchase the NSGC 44th Annual Conference General Sessions Package, click the blue "Register Now" button next to the package title. Do not register for the individual components included in the package.

    Genetic Counselor CEUs:

    The National Society of Genetic Counselors (NSGC) has authorized the National Society of Genetic Counselors (NSGC) to offer up to 4.45 CEUs or 44.5 Category 1 contact hours for the activity, NSGC 44th Annual Conference General Sessions Package. The American Board of Genetic Counseling (ABGC) will accept CEUs earned by participating in this program for the purposes of genetic counselor recertification.